西部中医药2024,Vol.37Issue(6) :98-102.DOI:10.12174/j.issn.2096-9600.2024.06.23

中医药靶向调控IL-6/JAK/STAT3通路的抗消化系统肿瘤研究进展

Progress of Anti-gastrointestinal Tumor Research by Targeting and Regulating IL-6/JAK/STAT3 Pathway in Chinese Medicine

李晓玲 吴玉泓 梁永林 李海龙
西部中医药2024,Vol.37Issue(6) :98-102.DOI:10.12174/j.issn.2096-9600.2024.06.23

中医药靶向调控IL-6/JAK/STAT3通路的抗消化系统肿瘤研究进展

Progress of Anti-gastrointestinal Tumor Research by Targeting and Regulating IL-6/JAK/STAT3 Pathway in Chinese Medicine

李晓玲 1吴玉泓 2梁永林 1李海龙1
扫码查看

作者信息

  • 1. 甘肃中医药大学,甘肃 兰州 730000
  • 2. 深圳大学附属华南医院,广东 深圳 518111
  • 折叠

摘要

就近年来白细胞介素6/非受体酪氨酸蛋白激酶/信号转导和转录激活因子3(interleukin-6/janus activated kinase/signal transducer and activator of transcription 3,IL-6/JAK/STAT3)信号通路在多种消化系统肿瘤中发挥的效应、中药单体及其活性成分、中药复方对与IL-6/JAK/STAT3信号通路调控有关的消化系统肿瘤中的防治作用进行综述,探究中医药在延缓、阻抑甚至逆转炎-癌转化中发挥的作用,为防治肿瘤提供更有力的理论指导.

Abstract

The paper reviewed the effects of interleukin-6/janus activated kinase/signal transducer and activator of transcription 3,IL-6/JAK/STAT3)signaling pathway in various digestive system tumors,the preventive and therapeutic effects of traditional Chinese medicine monomers and their active ingredients,and traditional Chinese medicine compounds on digestive system tumors related to the regulation of the IL-6/JAK/STAT3 signaling pathway in recent years.The role of traditional Chinese medicine in delaying,inhibiting,and even reversing inflammation-cancer transformation provides more powerful theoretical guidance for the prevention and treatment of tumors.

关键词

中医药/白细胞介素6/非受体酪氨酸蛋白激酶/信号转导和转录激活因子3信号通路/消化系统肿瘤/综述

Key words

Chinese medicine/interleukin 6/janus activated kinase/vated protein kinase/signal transducer and activator of transcription 3 signaling pathway/digestive system tumors/review

引用本文复制引用

基金项目

国家自然科学基金(81860810)

全国中医基础优秀人才研修项目(第四批)(J20184832009)

甘肃省中医药局项目(GZK-2018-5)

出版年

2024
西部中医药
甘肃中医药研究院

西部中医药

CSTPCD
影响因子:0.98
ISSN:1004-6852
参考文献量59
段落导航相关论文